
Uniwersytecki Szpital Kliniczny W Opolu
- Address
- Al. Wincentego Witosa 26
Sponsor Overview
Specializations
Peripheral Vascular Disease
Clinical research at Uniwersytecki Szpital Kliniczny W Opolu includes studies in lower extremity artery disease, with attention to superficial femoral artery restenosis and the management of patients treated with vascular stents.
- Restenosis prevention
- Endovascular stent treatment
- Colchicine
- Paclitaxel-eluting stents
The sponsor’s vascular research focuses on outcomes relevant to arterial re-narrowing and treatment strategies in peripheral arterial disease.
Critical Care Metabolic Support
The hospital also supports research in intensive care, particularly among patients with severe vitamin D3 deficiency receiving continuous renal replacement therapy.
- Critical illness
- Renal replacement therapy
- Enteral supplementation
- 25(OH)D3
These studies address the correction of micronutrient deficiency in patients with complex organ support needs in the intensive care unit.
Sponsored Trials
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 11 sites across their trial portfolio.
Therapeutic Focus
- 1.Cardiovascular Diseases1 trial359 other sponsors
- 2.Therapeutics1 trial87 other sponsors
Partnered Research Centres
11 centres- Address
- Ul. Wroclawska 1/3, 30-006 Krakow
- Address
- Ul. Ziolowa 45/47, 40-635 Katowice
- Address
- Ul. Lwowska 60, 35-301 Rzeszów
- Address
- Ul. Topolowa 16, 32-500 Chrzanow
- Address
- Ul. 3 Maja 13/15, 41-800 Zabrze
- Address
- Ul. Ceglowska 80, 01-809 Warsaw
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Uniwersytecki Szpital Kliniczny W Opolu.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.

